H Gao1, A Salim, J Lee, E S Tai, R M van Dam. 1. Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Abstract
OBJECTIVE: Diabetes in Asia constitutes approximately half of the global burden. Although insulin resistance and incidence of type 2 diabetes differ substantially between ethnic groups within Asia, the reasons for these differences are poorly understood. We evaluated to what extent body fatness, adiponectin levels and inflammation mediate the relationship between ethnicity and insulin resistance in an Asian setting. DESIGN: Cross-sectional population-based study. SUBJECTS: In total, 4136 adult Chinese, Malays and Asian Indians residing in Singapore. MEASUREMENTS: Insulin resistance was assessed using homeostasis model assessment (HOMA-IR) and systemic inflammation by C-reactive protein (CRP). Data were analyzed using path analysis. RESULTS: HOMA-IR was highest in Asian Indians, intermediate in Malays and lowest in Chinese (P<0.001). The difference in HOMA-IR between Malays and Chinese disappeared after adjusting for body mass index (BMI). For the comparison of Asian Indians with Chinese, the association between ethnicity and HOMA-IR was mediated by BMI (men: 32.9%; women: 48.5%), BMI-adjusted waist circumference (men: 6.1%; women: 3.5%), and CRP (men: 5.1%; women: 5.6%), and unidentified factors (men: 47.2%; women: 26.5%). Part of the mediating effects of body fatness was indirect through effects of body fatness on CRP and adiponectin concentrations. CONCLUSION: Mediators of ethnic differences in insulin resistance differed markedly depending on the ethnic groups compared. General adiposity explained the difference in insulin resistance between Chinese and Malays, whereas abdominal fat distribution, inflammation and unexplained factors contributed to excess insulin resistance in Asian Indians as compared with Chinese and Malays. These findings suggest that interventions targeting excess weight gain can reduce ethnic disparities in insulin resistance among Asian Indians, Chinese and Malays.
OBJECTIVE:Diabetes in Asia constitutes approximately half of the global burden. Although insulin resistance and incidence of type 2 diabetes differ substantially between ethnic groups within Asia, the reasons for these differences are poorly understood. We evaluated to what extent body fatness, adiponectin levels and inflammation mediate the relationship between ethnicity and insulin resistance in an Asian setting. DESIGN: Cross-sectional population-based study. SUBJECTS: In total, 4136 adult Chinese, Malays and Asian Indians residing in Singapore. MEASUREMENTS: Insulin resistance was assessed using homeostasis model assessment (HOMA-IR) and systemic inflammation by C-reactive protein (CRP). Data were analyzed using path analysis. RESULTS: HOMA-IR was highest in Asian Indians, intermediate in Malays and lowest in Chinese (P<0.001). The difference in HOMA-IR between Malays and Chinese disappeared after adjusting for body mass index (BMI). For the comparison of Asian Indians with Chinese, the association between ethnicity and HOMA-IR was mediated by BMI (men: 32.9%; women: 48.5%), BMI-adjusted waist circumference (men: 6.1%; women: 3.5%), and CRP (men: 5.1%; women: 5.6%), and unidentified factors (men: 47.2%; women: 26.5%). Part of the mediating effects of body fatness was indirect through effects of body fatness on CRP and adiponectin concentrations. CONCLUSION: Mediators of ethnic differences in insulin resistance differed markedly depending on the ethnic groups compared. General adiposity explained the difference in insulin resistance between Chinese and Malays, whereas abdominal fat distribution, inflammation and unexplained factors contributed to excess insulin resistance in Asian Indians as compared with Chinese and Malays. These findings suggest that interventions targeting excess weight gain can reduce ethnic disparities in insulin resistance among Asian Indians, Chinese and Malays.
Authors: Gaston M Astroza; Andreas Neisius; Matvey Tsivian; Agnes J Wang; Glenn M Preminger; Michael E Lipkin Journal: Int Urol Nephrol Date: 2014-08-19 Impact factor: 2.370
Authors: Xinyi Lin; Izzuddin M Aris; Mya Thway Tint; Shu E Soh; Keith M Godfrey; George Seow-Heong Yeo; Kenneth Kwek; Jerry Kok-Yen Chan; Peter D Gluckman; Yap Seng Chong; Fabian Yap; Joanna D Holbrook; Yung Seng Lee Journal: J Clin Endocrinol Metab Date: 2015-07-22 Impact factor: 5.958
Authors: Yide Yang; Ming Xie; Shuqian Yuan; Yuan Zeng; Yanhui Dong; Zhenghe Wang; Qiu Xiao; Bin Dong; Jun Ma; Jie Hu Journal: BMC Public Health Date: 2021-06-26 Impact factor: 3.295
Authors: Helen L Barrett; Marloes Dekker Nitert; Lee Jones; Peter O'Rourke; Karin Lust; Kathryn L Gatford; Miles J De Blasio; Suzette Coat; Julie A Owens; William M Hague; H David McIntyre; Leonie Callaway; Janet Rowan Journal: Diabetes Care Date: 2013-02-07 Impact factor: 19.112
Authors: Noraidatulakma Abdullah; John Attia; Christopher Oldmeadow; Rodney J Scott; Elizabeth G Holliday Journal: Int J Endocrinol Date: 2014-03-13 Impact factor: 3.257